Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04306315
What this trial is testing

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 385
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Study completedNCT01726933
What this trial is testing

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 839
Large-scale testing (Phase 3)Study completedNCT03598790
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 1,353
Testing effectiveness (Phase 2)Study completedNCT05096364
What this trial is testing

Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Akeso 251
Post-approval studies (Phase 4)Study completedNCT06032858
What this trial is testing

Efficacy and Safety of Apremilast in Psoriasis

Who this might be right for
Psoriasis
Ghurki Trust and Teaching Hospital 30
Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Post-approval studies (Phase 4)Looking for participantsNCT06857942
What this trial is testing

Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Who this might be right for
PsoriasisOverweight or Obesity
Eli Lilly and Company 200
Large-scale testing (Phase 3)Looking for participantsNCT07672561
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Zhejiang Wenda Pharma Technology LTD. 375
Testing effectiveness (Phase 2)Study completedNCT05364554
What this trial is testing

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 227
Testing effectiveness (Phase 2)Study completedNCT01230138
What this trial is testing

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH 252
Post-approval studies (Phase 4)WithdrawnNCT04488185
What this trial is testing

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Not applicableStudy completedNCT01401452
What this trial is testing

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 246
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330
What this trial is testing

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 80
Large-scale testing (Phase 3)Study completedNCT03849404
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 413
Testing effectiveness (Phase 2)Study completedNCT01585233
What this trial is testing

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Global Development, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Next Page